
Medicine and Health
CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics
L. Hao, R. T. Zhao, et al.
This research introduces a groundbreaking method for detecting and differentiating disease states using chemically stabilized nucleic acids multiplexed with synthetic biomarkers. Conducted by renowned researchers including Liangliang Hao and Sangeeta N. Bhatia, this innovative approach utilizes urine analysis through CRISPR-Cas detection mechanisms, paving the way for a convenient point-of-care diagnostic tool.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.